Cargando…

Visualization of Chronic Myocardial Infarction Using the Intravascular Contrast Agent MS-325 (Gadofosveset) in Patients

Aims. The aim of this study was to evaluate the potential of visualizing chronic myocardial infarction in patients using the intravascular CA MS-325 (gadofosveset, EPIX Pharmaceuticals, Mass, USA). Methods. Nine patients were enrolled in a clinical phase II multicenter trial for MRCA and perfusion i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thouet, Thomas, Schnackenburg, Bernhard, Kokocinski, Thomas, Fleck, Eckart, Nagel, Eike, Kelle, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific World Journal 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334354/ https://www.ncbi.nlm.nih.gov/pubmed/22536125 http://dx.doi.org/10.1100/2012/236401

Ejemplares similares

Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease
por: Klein, Christoph, et al.
Publicado: (2008)

MRI with gadofosveset: A potential marker for permeability in myocardial infarction
por: Lavin, Begoña, et al.
Publicado: (2018)

Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion in patients post bypass surgery
por: Klein, Christoph, et al.
Publicado: (2009)

Evaluation of contrast wash-in and peak enhancement in adenosine first pass perfusion CMR in patients post bypass surgery
por: Kelle, Sebastian, et al.
Publicado: (2010)

Value of strain analysis with feature tracking in adenosine stress myocardial perfusion magnetic resonance imaging
por: Schneeweis, Christopher, et al.
Publicado: (2014)

Comparison of myocardial tagging and feature tracking in patients with severe aortic stenosis
por: Schneeweis, Christopher, et al.
Publicado: (2013)

CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
por: Khan, SN, et al.
Publicado: (2013)

CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
por: Khan, Sarah N, et al.
Publicado: (2013)

Characterization of myocardium and myocardial motion in patients considered for transaortic valve implantation (TAVI)
por: Schneeweis, Christopher, et al.
Publicado: (2013)

Delayed Contrast-Enhanced MRI of the Coronary Artery Wall in Takayasu Arteritis
por: Schneeweis, Christopher, et al.
Publicado: (2012)

Delayed contrast-enhanced MRI of the coronary artery wall in patients with Takayasu's arteritis: initial experience and comparison to patients with stable coronary artery disease
por: Schneeweis, Christopher, et al.
Publicado: (2012)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Gadofosveset-enhanced magnetic resonance angiography
por: Goyen, Mathias
Publicado: (2008)

Potential Reduction of Interstitial Myocardial Fibrosis With Renal Denervation
por: Doltra, Adelina, et al.
Publicado: (2014)

High-dose dobutamine stress magnetic resonance perfusion imaging at 3.0 Tesla
por: Gebker, Rolf, et al.
Publicado: (2013)

Cardiovascular magnetic resonance stress perfusion imaging in patients with atrial fibrillation
por: Hucko, Thomas, et al.
Publicado: (2013)

Quantification of diffuse myocardial fibrosis in patients with resistant hypertension undergoing renal denervation versus hypertensive controls - preliminary results
por: Doltra, Adelina, et al.
Publicado: (2014)

Direct comparison of CMR dobutamine stress wall motion and perfusion analysis with adenosine perfusion in patients after bypass surgery
por: Klein, Christoph, et al.
Publicado: (2011)

Value of strain analysis with feature tracking in dobutamine stress cardiac magnetic resonance imaging for detecting coronary artery disease
por: Schneeweis, Christopher, et al.
Publicado: (2014)

Value of additional strain analysis with feature tracking in dobutamine stress cardiovascular magnetic resonance for detecting coronary artery disease
por: Schneeweis, Christopher, et al.
Publicado: (2014)

BOLD cardiovascular magnetic resonance at 3.0 tesla in myocardial ischemia
por: Manka, Robert, et al.
Publicado: (2010)

The role of dobutamine stress magnetic resonance in the clinical management of patients with coronary artery disease
por: Gebker, Rolf, et al.
Publicado: (2011)

The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease
por: Gebker, Rolf, et al.
Publicado: (2011)

Intraindividual comparison of circumferential strain using speckle tracking by echocardiography versus CMR feature tracking and myocardial tagging in patients
por: Schneeweis, Christopher, et al.
Publicado: (2015)

High-dose dobutamine stress SSFP cine MRI at 3 Tesla with patient adaptive local RF shimming using dual-source RF transmission
por: Berger, Alexander, et al.
Publicado: (2012)

High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol
por: Shahrouki, Puja, et al.
Publicado: (2021)

Non-invasive quantification of anatomical and functional renal artery vessel wall changes in patients with resistant hypertension undergoing renal denervation using MRI
por: Doltra, Adelina, et al.
Publicado: (2014)

Gadofosveset trisodium in coronary magnetic resonance angiography at 3 Tesla
por: Raman, Fabio S, et al.
Publicado: (2014)

Overcoming the Low Relaxivity of Gadofosveset at High Field with Spin Locking
por: Richardson, O C, et al.
Publicado: (2012)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

Myocardial T1 mapping and determination of partition coefficients at 3 tesla: comparison between gadobenate dimeglumine and gadofosveset trisodium
por: Nacif, Marcelo Souto, et al.
Publicado: (2018)

Differential MR Delayed Enhancement Patterns of Chronic Myocardial Infarction between Extracellular and Intravascular Contrast Media
por: Wang, Jian, et al.
Publicado: (2015)

Dobutamine stress cardiovascular magnetic resonance at 3 Tesla
por: Kelle, S, et al.
Publicado: (2008)

Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
por: Schreinemacher, Marc H., et al.
Publicado: (2012)

Optimization of gadofosveset intravenous injection scheme for coronary MRA: the pharmacokinetics approach
por: Ahlman, Mark A, et al.
Publicado: (2014)

Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
por: Doltra, Adelina, et al.
Publicado: (2013)

Myocardial T2 mapping for improved detection of inflammatory myocardial involvement in acute and chronic myocarditis
por: Hinojar, Rocio, et al.
Publicado: (2014)

Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction
por: Hong, Young Joon, et al.
Publicado: (2015)

CMR Assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset
por: Pedersen, Steen F, et al.
Publicado: (2011)

Imaging of aortic coarctation using Gd-DTPA and Gadofosveset: a comparative study
por: Greil, Gerald F, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lo3oktv4umrbfibnk6lk3db95t